MEDICAL INFORMATION TECHNOLOGY, INC.
BALANCE SHEET
DECEMBER 31, 2020 AND MARCH 31, 2021

BALANCE SHEETDec 31, 2020Mar 31, 2021
Cash and Equivalents
Marketable Securities
Trade Receivables, Net of Reserve
Contract Assets, Prepaid and Other
40,504,119
323,777,971
40,812,984
16,089,907
37,407,020
342,983,275
21,656,795
17,653,088
  Current Assets421,184,981419,700,178
Computer Equipment
Furniture and Fixtures
Buildings
Land
Accumulated Depreciation
12,937,048
76,366,841
190,105,517
26,717,577
(146,741,211)
13,386,517
76,395,261
190,105,517
26,717,577
(149,505,589)
  Fixed Assets159,385,772157,099,283
Other Assets
Deferred Tax Assets
7,101,280
8,140,309
7,096,760
7,758,371
  TOTAL ASSETS595,812,342591,654,592
Accounts Payable
Taxes Payable
Accrued Expenses
Deferred Revenue
168,728
2,865,409
27,927,555
43,361,221
205,066
2,019,283
18,564,513
44,446,345
  Current Liabilities74,322,91365,235,207
Deferred Tax Liabilities
Tax Reserves
25,244,294
15,303,393
27,876,544
15,217,593
  TOTAL LIABILITIES114,870,600108,329,344
Common Stock
Additional Paid-in Capital
Retained Income
7,106
85,353,277
395,581,359
7,106
85,353,277
397,964,865
  SHAREHOLDER EQUITY480,941,742483,325,248
  TOTAL LIABILITIES AND EQUITY595,812,342591,654,592
Shares Outstanding
Shareholder Equity Per Share
7,106
$67,681.08
7,106
$68,016.50

MEDICAL INFORMATION TECHNOLOGY, INC.
INCOME STATEMENT
3 MONTHS ENDED ON MARCH 31, 2020 AND 2021

INCOME STATEMENTMar 31, 2020Mar 31, 2021
Product Revenue
Service Revenue
MaaS Revenue
58,136,197
83,491,056
1,146,008
20,789,006
84,964,950
4,756,435
  TOTAL REVENUE142,773,261110,510,391
  OPERATING EXPENSE111,387,932100,788,814
  OPERATING INCOME31,385,3299,721,577
Other Income
Change in Unrealized Gains
Other Expense
5,411,201
(75,197,644)
896,054
3,804,064
10,955,619
497,754
  PRETAX (LOSS) INCOME(39,297,168)23,983,506
States Income (Benefit) Tax
Federal Income (Benefit) Tax
(1,759,000)
(11,808,000)
497,000
3,338,000
  INCOME (BENEFIT) TAX(13,567,000)3,835,000
  NET (LOSS) INCOME(25,730,168)21,148,506
Average Shares Outstanding
Net (Loss) Income Per Share
Dividends Paid Per Share
7,438
($3,459.21)
$2,800.
7,106
$2,835.42
$2,500.

MEDICAL INFORMATION TECHNOLOGY, INC.
SHAREHOLDER EQUITY STATEMENT
3 MONTHS ENDED ON MARCH 31, 2020 AND 2021

SHAREHOLDER EQUITY STATEMENTMar 31, 2020Mar 31, 2021
Shareholder Equity at Beginning of Period
Net Income
Dividends Paid
557,750,408
(25,730,168)
(20,826,878)
480,941,742
20,148,506
(17,765,000)
  SHAREHOLDER EQUITY AT END OF PERIOD511,193,362483,325,248

MEDICAL INFORMATION TECHNOLOGY, INC.
CASH FLOW STATEMENT
3 MONTHS ENDED ON MARCH 31, 2020 AND 2021

CASH FLOW STATEMENTMar 31, 2020Mar 31, 2021
Net (Loss) Income
Depreciation Expense
Change in Marketable Securities
Change in Trade Receivables, Net of Reserve
Change in Contract Assets, Prepaid and Other
Change in Deferred Tax Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Accrued Expenses
Change in Deferred Revenue
Change in Deferred Tax Liabilities
Change in Tax Reserves
(25,730,168)
3,130,413
75,197,644
(4,664,969)
(5,832,908)
(45,113)
490,878
1,883,953
(4,816,983)
(1,394,046)
(18,037,168)
(448,248)
20,148,506
2,764,378
(10,955,619)
19,156,189
(1,563,181)
381,938
36,338
(846,126)
(9,363,042)
1,085,124
2,632,250
(85,800)
  NET CASH FROM OPERATIONS19,733,28523,390,955
Purchase of Marketable Securities 
Sales of Marketable Securities
Purchases of Fixed Assets
Change in Other Assets
--
10,000,000
(1,033,159)
19,611
(8,249,685)
--
(477,889)
4,520
  NET CASH  FROM (USED IN) INVESTING8,986,452(8,723,054)
Dividends Paid(20,826,878)(17,765,000)
  NET CASH USED IN FINANCING(20,826,878)(17,765,000)
NET CHANGE IN CASH AND EQUIVALENTS
CASH AND EQUIVALENTS AT BEGINNING OF YEAR
7,892,859
14,997,613
(3,097,099)
40,504,119
  CASH AT END OF PERIOD22,890,47237,407,020